CDC50A and cancer: As discussed again below, the recent characterization of somatic mutations in P4-ATPases, TMEM30A proteins, and PS scramblases could implicate a broader involvement in solid cancers that may contribute to PS dysregulation in tumors and potentially a mechanism for cell intrinsic immune escape in cancer via constitutive PS externalization observed in many solid cancers [59].